We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Trimel Pharmaceuticals Corporation Completes Patient Enrollment of CompleoTRT Phase III Safety Cohort

News   Jan 18, 2012

 
Trimel Pharmaceuticals Corporation Completes Patient Enrollment of CompleoTRT Phase III Safety Cohort
 
 
 

RELATED ARTICLES

Gene Therapy for Duchenne Muscular Dystrophy Successful in Pigs

News

An interdisciplinary Munich research team led by scientists from TUM has for the first time succeeded in correcting the mutated dystrophin gene in living pigs. In order to cut the defective gene sequence from the DNA of the animals' muscle and heart cells, the researchers modified the Crispr-Cas9 gene scissors.

READ MORE

Human Body-on-Chip Systems Boost Drug Testing Capabilities

News

A team of researchers has designed a comprehensive multi-organ-on-a-chip platform that supports effective in vitro-to-in vivo translation of human drug pharmacology.

READ MORE

Vaccine for African Swine Fever Virus Shows Promise

News

Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE